Pharmacodynamics: Drug-Target Interactions and Dose-Response

Challenge Debrief: Drug Administration

• Original Scenario: Professors intoxicated by a peptide-based compound, quick effect, no injection/transdermal marks, suspicious stain on clothing.

• Pharmacological Reasoning:

  • Peptides are susceptible to degradation by proteases and acidic pH in the stomach, ruling out oral administration.

  • Transdermal absorption is slow, inconsistent with the quick effect observed.

  • The most probable route was sublingual/buccal (under the tongue/cheek), allowing rapid absorption into systemic circulation, bypassing first-pass metabolism, and aligning with the quick onset of action.

Introduction to Pharmacodynamics

• Definition: The study of how a drug produces a biological effect in the body.

• Mechanism of Drug Action (MOA): A multi-step process:

  1. Interaction between the drug and its molecular target.

  2. Impact of this interaction on cell function.

  3. Subsequent signaling events leading to the observed effect.

Molecular Targets of Drugs

• Most drugs bind to macromolecules (collectively termed "receptors" in pharmacology for ease).

• Common primary molecular targets include:

  • Receptors: Often coupled with signaling pathways.

  • Enzymes

  • Ion Channels

  • Transporters

• Drugs can activate (agonists) or inhibit (antagonists) these pathways.

• Endogenous molecules naturally bind to these receptors; synthetic drugs mimic these to produce similar effects.

Characteristics of Drug-Target Interaction

• Affinity:

  • The strength of binding between a drug and its target.

  • Higher affinity means stronger interaction.

  • Explains why drugs act in specific parts of the body where complementary receptors are concentrated.

• Selectivity:

  • The ability of a drug to discriminate between different targets.

  • Highly selective drugs bind primarily to their intended target, minimizing off-target effects (side effects).

  • Less selective drugs bind to multiple targets, leading to more widespread effects and potentially adverse reactions (e.g., tricyclic antidepressants vs. SSRIs).

• Reversibility:

  • Most drug-receptor interactions are reversible, meaning the drug can bind and detach, indicated by double arrows in reaction schemes (Drug + Receptor $\rightleftharpoons$ Drug-Receptor Complex).

  • Irreversible interactions form very strong bonds (e.g., covalent bonds), where the drug-receptor complex cannot easily dissociate. The duration of effect for irreversible binding depends on the turnover of the receptor.

• Chemical Forces: The strength and reversibility of binding are determined by chemical forces:

  • Covalent Bonds: Strongest, irreversible, involves electron sharing.

  • Ionic Bonds: Attraction between opposing charges.

  • Hydrogen Bonds: Attraction involving a hydrogen atom and an electronegative atom (e.g., oxygen).

  • Van der Waals Forces: Weak, transient attractive forces between polarized molecules.

  • Most drugs bind via multiple-weak interactions.

• Saturability (Law of Mass Action):

  • The rate and magnitude of drug effect are proportional to the amount of drug available, leading to more drug-receptor complexes.

  • Interactions are finite; there is a limited number of receptors.

  • Adding more drug beyond a certain point will not increase the effect once all available receptors are occupied, leading to saturation and a maximal effect.

  • Binding can be quantified: (% receptors bound) $=$ (concentration of bound receptors) $/$ (total receptors).

Dose-Response Relationships

• Dose-Response Curves: Graphical representation of the relationship between drug dose/concentration and the magnitude of the biological effect.

  • Graded Dose-Response Curves: Measure the effect in a single biological system (tissue or individual) across varying drug concentrations.

  • Concentration Scale: Often uses a logarithmic scale for concentration to visualize a wide range of drug effects, resulting in a sigmoid curve.

• Key Parameters from Curves:

  • Threshold: Minimum drug concentration required to produce a visible or measurable effect.

  • Maximal Effect (Emax): The greatest response that can be produced by the drug; reached when all available receptors are occupied (saturation).

  • $EC_{50}$ (Effective Concentration 50%): The concentration of drug that produces $50\%$ of the maximum possible effect.

• Spare Receptors: In some systems, the maximum effect can be achieved without occupying all receptors.

Efficacy and Potency

• Efficacy:

  • The maximum biological response that a drug can produce ($E_{max}$).

  • Reflects how well a drug activates its target once bound.

  • Example: Morphine has higher efficacy for pain relief than Tylenol.

  • Determined by intrinsic activity (the drug's ability to trigger a response after binding).

• Potency:

  • The amount of drug (concentration or dose) required to produce an effect of a given magnitude, typically $EC_{50}$.

  • A drug with a lower $EC_{50}$ is more potent, meaning less drug is needed to achieve a specific effect.

  • Example: Carfentanil is more potent than Fentanyl or Heroin, requiring a much smaller dose for an effect.

• Independence: Efficacy and potency are independent characteristics; a drug can be highly potent but have low efficacy, or vice-versa. Clinicians choose drugs based on therapeutic goals, considering both efficacy and side effect profiles, not always needing the most efficacious or potent option.